Pharsight

Famvir patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6124304 NOVARTIS Penciclovir for the treatment of zoster associated pain
Oct, 2014

(9 years ago)

US5866581 NOVARTIS Penciclovir for the treatment of post therapeutic neuralgia
Oct, 2014

(9 years ago)

US6124304

(Pediatric)

NOVARTIS Penciclovir for the treatment of zoster associated pain
Apr, 2015

(9 years ago)

US5866581

(Pediatric)

NOVARTIS Penciclovir for the treatment of post therapeutic neuralgia
Apr, 2015

(9 years ago)

US5916893 NOVARTIS Treatment of a latent infection of herpes virus
Sep, 2015

(8 years ago)

US5840763 NOVARTIS Treatment of a latent infection of herpes viruses
Sep, 2015

(8 years ago)

US5840763

(Pediatric)

NOVARTIS Treatment of a latent infection of herpes viruses
Mar, 2016

(8 years ago)

US5916893

(Pediatric)

NOVARTIS Treatment of a latent infection of herpes virus
Mar, 2016

(8 years ago)

Famvir is owned by Novartis.

Famvir contains Famciclovir.

Famvir has a total of 8 drug patents out of which 8 drug patents have expired.

Expired drug patents of Famvir are:

  • US6124304
  • US5866581
  • US6124304*PED
  • US5866581*PED
  • US5916893
  • US5840763
  • US5840763*PED
  • US5916893*PED

Famvir was authorised for market use on 11 December, 1995.

Famvir is available in tablet;oral dosage forms.

Famvir can be used as method of treating varicella zoster (shingles) infections.

The generics of Famvir are possible to be released after 01 March, 2016.

Drug Exclusivity Drug Exclusivity Expiration
M(M-54) Dec 24, 2012
M(M-98) Jan 31, 2014
M(M-112) Feb 09, 2015
Pediatric Exclusivity(PED) Jun 24, 2013

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using FAMCICLOVIR ingredient

Market Authorisation Date: 11 December, 1995

Treatment: Method of treating varicella zoster (shingles) infections

Dosage: TABLET;ORAL

How can I launch a generic of FAMVIR before it's drug patent expiration?
More Information on Dosage

FAMVIR family patents

Family Patents